RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 147 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,710,741 | +39.0% | 2,909,956 | 0.0% | 5.15% | +40.6% |
| Q2 2023 | $47,985,174 | -7.6% | 2,909,956 | 0.0% | 3.66% | +2.1% |
| Q1 2023 | $51,913,615 | -63.7% | 2,909,956 | -40.7% | 3.59% | -55.3% |
| Q4 2022 | $142,977,919 | +32.0% | 4,909,956 | -0.0% | 8.04% | +48.6% |
| Q3 2022 | $108,316,000 | +431.3% | 4,912,306 | 0.0% | 5.41% | +416.4% |
| Q2 2022 | $20,386,000 | -64.0% | 4,912,306 | 0.0% | 1.05% | -36.0% |
| Q1 2022 | $56,590,000 | +15.4% | 4,912,306 | 0.0% | 1.64% | +65.0% |
| Q4 2021 | $49,025,000 | -23.6% | 4,912,306 | 0.0% | 0.99% | +30.1% |
| Q3 2021 | $64,155,000 | -33.3% | 4,912,306 | 0.0% | 0.76% | -39.2% |
| Q2 2021 | $96,183,000 | -7.9% | 4,912,306 | 0.0% | 1.25% | -46.6% |
| Q1 2021 | $104,485,000 | -26.9% | 4,912,306 | 0.0% | 2.34% | -37.9% |
| Q4 2020 | $142,948,000 | +34.3% | 4,912,306 | 0.0% | 3.77% | -16.3% |
| Q3 2020 | $106,450,000 | -2.8% | 4,912,306 | 0.0% | 4.51% | +2.3% |
| Q2 2020 | $109,544,000 | +46.5% | 4,912,306 | 0.0% | 4.40% | +12.7% |
| Q1 2020 | $74,765,000 | -33.7% | 4,912,306 | 0.0% | 3.91% | -26.8% |
| Q4 2019 | $112,787,000 | +6.3% | 4,912,306 | 0.0% | 5.33% | -39.3% |
| Q3 2019 | $106,057,000 | -1.9% | 4,912,306 | 0.0% | 8.78% | +16.0% |
| Q2 2019 | $108,071,000 | -19.7% | 4,912,306 | 0.0% | 7.57% | +8.3% |
| Q1 2019 | $134,646,000 | +2.0% | 4,912,306 | 0.0% | 6.99% | +33.5% |
| Q4 2018 | $132,043,000 | -7.9% | 4,912,306 | 0.0% | 5.24% | -15.3% |
| Q3 2018 | $143,292,000 | -6.7% | 4,912,306 | 0.0% | 6.18% | -14.1% |
| Q2 2018 | $153,559,000 | +57.1% | 4,912,306 | 0.0% | 7.19% | +65.5% |
| Q1 2018 | $97,755,000 | -31.5% | 4,912,306 | 0.0% | 4.35% | -26.5% |
| Q4 2017 | $142,752,000 | – | 4,912,306 | – | 5.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,075,000 | $47,569,375 | 5.56% |
| NEA Management Company, LLC | 2,909,956 | $66,710,741 | 5.15% |
| Opaleye Management Inc. | 653,000 | $14,970,025 | 4.87% |
| Frazier Life Sciences Management, L.P. | 2,371,304 | $54,362,144 | 3.61% |
| VR Adviser, LLC | 1,090,000 | $24,988,250 | 2.63% |
| RA Capital Management | 5,676,067 | $130,123,836 | 2.56% |
| Samsara BioCapital, LLC | 345,293 | $7,915,842 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 260,537 | $5,972,811 | 1.81% |
| Logos Global Management LP | 400,000 | $9,170,000 | 1.22% |
| Cormorant Asset Management, LP | 850,000 | $19,486,250 | 1.14% |